arsalandywriter.com

New England February 2021 Venture Deals Overview

Written on

We are excited to present our monthly summary of venture deals! According to data from Crunchbase, February 2021 witnessed a surge in activity in New England, with over 50 recorded deals spanning from Pre-Seed to Series E. This highlights the robust startup and venture capital landscape in the region, reflecting a broader trend in venture capital activity. Below is the compilation of notable deals from the month:

Company: Cellino Biotech HQ: Cambridge, MA Stage: Seed Round Size: $16,000,000

Company: Lumeda HQ: Rocky Hill, CT Stage: Seed Round Size: $2,750,000

Company: FOLX Health HQ: Boston, MA Stage: Series A Round Size: $25,000,000

Company: Dealer Policy HQ: Williston, VT Stage: Series B Round Size: $30,000,000

Company: Reverie Labs HQ: Boston, MA Stage: Series A Round Size: $25,000,000

Company: Frontier Nutrition HQ: New Haven, CT Stage: Series B Round Size: $6,000,000

Company: Spectrawave HQ: Waltham, MA Stage: Series A Round Size: $13,200,000

Company: Verb Data HQ: Boston, MA Stage: Pre-Seed Round Size: Undisclosed

Company: Metalenz HQ: Cambridge, MA Stage: Series A Round Size: $10,000,000

Company: Inivata HQ: Cambridge, MA Stage: Series C Round Size: $35,000,000

Company: DataCebo HQ: Weston, MA Stage: Seed Round Size: $2,999,997

Company: Rubik Therapeutics HQ: Boston, MA Stage: Seed Round Size: Undisclosed

Company: Thrasio HQ: Walpole, MA Stage: Series D Round Size: $750,000,000

Company: Beam Organics HQ: Boston, MA Stage: Series A Round Size: $5,000,000

Company: InteRNA Technologies HQ: New Haven, CT Stage: Series B Round Size: $22,500,000

Company: Rubix LS HQ: Lawrence, MA Stage: Seed Round Size: $1,250,000

Company: Boston Metal HQ: Woburn, MA Stage: Series B Round Size: $50,000,000

Company: Aidentified HQ: Boston, MA Stage: Series A Round Size: $10,000,000

Company: Premama HQ: Providence, RI Stage: Series A Round Size: Undisclosed

Company: Nobl9 HQ: Waltham, MA Stage: Series B Round Size: $21,000,000

Company: Hyperfine Research HQ: Guilford, CT Stage: Series D Round Size: $90,000,000

Company: Rhino Health HQ: Cambridge, MA Stage: Seed Round Size: $5,000,000

Company: Cytier Therapeutics HQ: Cambridge, MA Stage: Series C Round Size: $80,000,000

Company: Ensoma HQ: Boston, MA Stage: Series A Round Size: $70,000,000

Company: Centessa Pharmaceuticals HQ: Cambridge, MA Stage: Series A Round Size: $250,000,000

Company: AdmitHub HQ: Boston, MA Stage: Series B Round Size: $14,000,000

Company: GPMS HQ: Burlington, VT Stage: Series A Round Size: Undisclosed

Company: OutSystems HQ: Boston, MA Stage: Series E Round Size: $150,000,000

Company: Locus Robotics HQ: Wilmington, MA Stage: Series E Round Size: $150,000,000

Company: Elicio Therapeutics HQ: Cambridge, MA Stage: Series B Round Size: $73,000,000

Company: KinoTek HQ: Portland, ME Stage: Pre-Seed Round Size: $600,000

Company: FinTron Invest HQ: Fairfield, CT Stage: Seed Round Size: $750,000

Company: PaerPay HQ: Boston, MA Stage: Pre-Seed Round Size: Undisclosed

Company: SalioGen Therapeutics HQ: Burlington, MA Stage: Series A Round Size: $20,000,000

Company: Reprise HQ: Boston, MA Stage: Series A Round Size: $17,000,000

Company: Regor Therapeutics HQ: Boston, MA Stage: Series B Round Size: $90,000,000

Company: ABclonal HQ: Woburn, MA Stage: Series C Round Size: $93,000,000

Company: Project Well HQ: Stamford, CT Stage: Seed Round Size: $2,000,000

Company: Kompany39 HQ: Manchester, NH Stage: Seed Round Size: $730,000

Company: THEON Therapeutics HQ: Boston, MA Stage: Seed Round Size: $2,850,000

Company: Malta HQ: Cambridge, MA Stage: Series B Round Size: $50,000,000

Company: Xilio Therapeutics HQ: Waltham, MA Stage: Series C Round Size: $95,000,000

Company: Orna Therapeutics HQ: Cambridge, MA Stage: Series A Round Size: $80,000,000

Company: Highland Instruments HQ: Braintree, MA Stage: Seed Round Size: $750,000

Company: Medisafe HQ: Boston, MA Stage: Series C Round Size: $30,000,000

Company: Cellarity HQ: Cambridge, MA Stage: Series B Round Size: $125,000,000

Company: Clinical Research IO HQ: Boston, MA Stage: Series A Round Size: $2,000,000

If you’ve reached this point, it’s clear you have a keen interest in the startup and venture capital scene, especially in New England. If that resonates with you, consider subscribing to _The Buzz_. This community fosters connections between startups and investors, mentors, and advisors, promoting mutually beneficial relationships. You can subscribe using the link below:

<div class="link-block">

<div>

<h2>Subscribe To The Buzz</h2>

<div><h3>Edit description</h3></div>

<div><p>mailchi.mp</p></div>

</div>

</div>

Share the page:

Twitter Facebook Reddit LinkIn

-----------------------

Recent Post:

Understanding Anxiety: Symptoms and Effective Relief Strategies

Discover symptoms of anxiety and effective strategies for managing it, enhancing your daily life and well-being.

Unlocking the Potential of AI for Neurodivergent Individuals

Explore how AI can empower neurodivergent individuals in various life aspects.

The Unusual Journey of Germany's Jungle Girl: A Tale of Survival

Discover the extraordinary life of Sabine Kuegler, a German girl raised in the jungles of Indonesia, navigating two vastly different worlds.

Unlocking the Keys to a Meaningful Life: Goals, Self-Discovery, and Positivity

Explore how goal-setting and self-discovery can enhance your life, creating a path toward fulfillment and positivity.

Unlocking the Secrets of a Substack Bestseller: Insights and Tips

Discover how a Substack bestseller achieved 6,000 subscribers and a 32% open rate through personal storytelling and effective strategies.

# Effective Exercise Modifications for Beginners to Succeed

Explore five beginner-friendly exercise modifications to build a solid foundation in fitness, enhancing your health and confidence.

Navigating Relationships with Difficult Neighbors: A Practical Guide

Discover effective strategies for managing challenging neighbor relationships while maintaining peace in your community.

The Rise and Fall of Webvan: Lessons in Online Grocery Delivery

Explore the story of Webvan, a pioneering online grocery service that faced challenges and ultimately failed, offering critical lessons for modern startups.